Cargando…
Anti-tuberculosis treatment strategies and drug development: challenges and priorities
Despite two decades of intensified research to understand and cure tuberculosis disease, biological uncertainties remain and hamper progress. However, owing to collaborative initiatives including academia, the pharmaceutical industry and non-for-profit organizations, the drug candidate pipeline is p...
Autores principales: | Dartois, Véronique A., Rubin, Eric J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045034/ https://www.ncbi.nlm.nih.gov/pubmed/35478222 http://dx.doi.org/10.1038/s41579-022-00731-y |
Ejemplares similares
-
Drug development challenges in nontuberculous mycobacterial lung disease: TB to the rescue
por: Dartois, Véronique, et al.
Publicado: (2022) -
The Role of Transport Mechanisms in Mycobacterium Tuberculosis Drug Resistance and Tolerance
por: Sarathy, Jansy Passiflora, et al.
Publicado: (2012) -
Critical discussion on drug efflux in Mycobacterium tuberculosis
por: Remm, Sille, et al.
Publicado: (2021) -
Challenges in the development of drugs for the treatment of tuberculosis
por: Shehzad, Adeeb, et al.
Publicado: (2013) -
Translational Research for Tuberculosis Elimination: Priorities, Challenges, and Actions
por: Lienhardt, Christian, et al.
Publicado: (2016)